MMCAP International’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

MMCAP International’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,566	Closed	-$50K	–	456
2022 Q3	$50K	Hold	66,566	–	–	﹤0.01%	301
2022 Q2	$5K	Hold	66,566	–	–	﹤0.01%	466
2022 Q1	$15K	Hold	66,566	–	–	﹤0.01%	493
2021 Q4	$39K	Hold	66,566	–	–	﹤0.01%	420
2021 Q3	$45K	Hold	66,566	–	–	﹤0.01%	392
2021 Q2	$74K	Sell	66,566 -100	-0.2%	-$100	﹤0.01%	363
2021 Q1	$60K	Buy	+66,666	New	+$113K	0.01%	304

MMCAP International's FLACW Position: Q4 2022 in Review

MMCAP International sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 66,566 shares — an estimated $50K sold.

MMCAP International first reported a position in FLACW in Q1 2021 and held it in 7 quarters. The position peaked at $74K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

MMCAP International reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
MMCAP International sold 66,566 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $50K.
MMCAP International first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
MMCAP International's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $74K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on MMCAP International's 13F filing for Q4 2022, filed 9 Feb 2023.